Travere Therapeutics stockTVTX
Travere Therapeutics trades at $48.87, 28.9% below its 52-week high (Sep 11, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +27.9% year to date, +44.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for TVTX — after you log in
Open the terminalFrequently asked questions about Travere Therapeutics
What is the Travere Therapeutics stock price?
At the close on Nov 5, 2026: $48.87 (−6.77% on the day). 52-week high: $68.73 on Sep 11, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Travere Therapeutics report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed −296% year over year, revenue +36%.
Does Travere Therapeutics pay dividends?
No, Travere Therapeutics does not pay dividends.
Where does Travere Therapeutics trade and how to buy it?
Ticker TVTX, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Travere Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for TVTX are in the terminal after you log in.